Searched for
NIKHIL CHOPRA
JB Pharma Q2 Results: Net profit jumps 16% to Rs 175 crore, revenue up 13%JB Pharma reported a 16% YoY increase in Q2FY25 net profit to Rs 175 crore, driven by 22% growth in domestic business. Revenues rose 13% to...- JB Pharma Q1 Results: Net profit rises 25% YoY to Rs 177 cr"Our overall performance in the first quarter has been robust. We have reached a new milestone of Rs 1,000 crore in quarterly sales for the...
- JB Pharma expects India business to grow above market growth rate in FY25: CEO Nikhil ChopraJB Pharma, led by CEO Nikhil Chopra, forecasts 12-14% revenue growth and aims to increase Ebitda margins by 27-28% in FY25. The growth is d...
- Mithun Manhas, Nikhil Chopra, junior selector Krishan Mohan in race to become BCCI selectorFormer India spinner Nikhil Chopra, Delhi veteran Mithun Manhas, and current junior selector Krishan Mohan are contenders for a BCCI select...
- JB Pharma Q2 Results: Net profit jumps 35% YoY to Rs 151 croreRevenue for the quarter rose 9% YoY to Rs 882 crore. The Mumbai-based company reported operating earnings before interest, taxes, depreciat...
- JB Pharma acquires cardiac brand from Glenmark for Rs 314 croreJB Pharma on Wednesday said it has acquired cardiac brand Razel (rosuvastatin) for India and Nepal region from Glenmark for Rs 314 crore in...
- JB Chemicals & Pharma Q2 profit up 13% at Rs 111 cr"Our market-beating performance in domestic business was sustained through growth in our organic portfolio, with big brands getting bigger;...
- KKR-backed JBCPL unveils new logo & identity“In 45 years, we at JB have built a strong foundation of integrity, trust and reliability. Now we are taking the next leap forward towards ...
- JB Chemicals & Pharma posts Rs 119 cr net profit in Q1Consolidated revenue from operations of the company stood at Rs 606 crore for the quarter under consideration. It was Rs 522.3 crore for th...
- JB Chemicals & Pharma Q4 results: Net profit jumps two-fold to Rs 101 crConsolidated revenue from operations stood at Rs 528 crore for the quarter under consideration. It was Rs 444 crore for the same period a y...
- JB Chemicals and Pharmaceuticals CEO wants to visit Masai Mara with his sonNikhil Chopra said that this trip will be the perfect bonding time for the father-son duo.
- Cipla witnesses 3 senior-level exits including India biz CEODrug firm Cipla has witnessed three senior-level exits, including that of the company's Executive Vice-President and CEO for India business...
- Cipla launches generic version of remdesivir at Rs 4,000 per vial"We are proud to commercially launch Cipremi today (on Wednesday); amongst the lowest priced globally, and aim to supply over 80,000 vials ...
- Cipla acquires 4 key brands from Wanbury for up to Rs 89 croreThe nutraceutical products, to be sold under the 4 umbrella brands, would address various health needs for conditions arising due to nutrit...
- This Navratri, brighten up your kitchen with soft, glossy hues; say no to dark shadesDark colours make kitchen space look smaller.
- Delhi Airport hosts Skylympics-aviation multi-sport eventThe three-day event was inaugurated by the national sports icons - Shooter- Gagan Narang and Cricketer Nikhil Chopra.
- Delhi High Court raps DDCA on its decision to remove 3 selectorsThe sports working committee of DDCA removed former Indian cricketers Maninder Singh, Atul Wassan and Nikhil Chopra from their respective p...
- Cipla inks pact with US firm for Ropivacaine infusion systemDrug major Cipla has inked a pact with US-based BioQ Pharma for registration and commercialisation of latter's Ropivacaine infusion system.
- Air India connects Delhi and Colombo with a non-stop flightThe flight - AI 275 from Delhi - will leave at 1200 hours and reach Colombo at 1535 hours except on Wednesdays when the flight will leave D...
- Axa-Bharti lines up MF, non-life forayFrance’s Axa Group will pursue a joint venture in mutual funds and non-life insurance with its life insurance partner Bharti group.
Load More
